Literature DB >> 3025858

Suppressive effect on polyclonal B-cell activation of a synthetic peptide homologous to a transmembrane component of oncogenic retroviruses.

M Mitani, G J Cianciolo, R Snyderman, M Yasuda, R A Good, N K Day.   

Abstract

Purified feline leukemia virus, UV light-inactivated feline leukemia virus, and a synthetic peptide (CKS-17) homologous to a well-conserved region of the transmembrane components of several human and animal retroviruses were each studied for their effects on IgG production by feline peripheral blood lymphocytes. Using a reverse hemolytic plaque assay, both the viable virus and the UV-inactivated feline leukemia virus, but not the CKS-17, activated B lymphocytes to secrete IgG. When staphylococcal protein A, a polyclonal B-cell activator, was used to stimulate IgG synthesis by feline lymphocytes, the viable virus, the UV-inactivated virus, and the CKS-17 peptide each strongly suppressed IgG secretion without compromising viability of the lymphocytes. These findings suggest that the immunosuppressive influences of feline leukemia virus on immunoglobulin synthesis may reside in a conserved portion of the envelope glycoprotein that includes the region homologous to CKS-17.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3025858      PMCID: PMC304178          DOI: 10.1073/pnas.84.1.237

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  REDUCED ANTIBODY FORMING CAPACITY DURING THE INCUBATION PERIOD OF PASSAGE A LEUKEMIA IN C3H MICE.

Authors:  R D PETERSON; R HENDRICKSON; R A GOOD
Journal:  Proc Soc Exp Biol Med       Date:  1963-11

2.  A DEFECT IN CELLULAR IMMUNITY DURING THE INCUBATION PERIOD OF PASSAGE A LEUKEMIA IN C3H MICE.

Authors:  P B DENT; R D PETERSON; R A GOOD
Journal:  Proc Soc Exp Biol Med       Date:  1965-07

3.  Macrophage accumulation in mice is inhibited by low molecular weight products from murine leukemia viruses.

Authors:  G J Cianciolo; T J Matthews; D P Bolognesi; R Snyderman
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

4.  Abrogation of lymphocyte blastogenesis by a feline leukaemia virus protein.

Authors:  L E Mathes; R G Olsen; L C Hebebrand; E A Hoover; J P Schaller
Journal:  Nature       Date:  1978-08-17       Impact factor: 49.962

5.  Suppression of the respiratory burst of human monocytes by a synthetic peptide homologous to envelope proteins of human and animal retroviruses.

Authors:  R A Harrell; G J Cianciolo; T D Copeland; S Oroszlan; R Snyderman
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

Review 6.  Effects of tumor growth on host defenses.

Authors:  G J Cianciolo; R Snyderman
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

7.  Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome.

Authors:  H C Lane; H Masur; L C Edgar; G Whalen; A H Rook; A S Fauci
Journal:  N Engl J Med       Date:  1983-08-25       Impact factor: 91.245

8.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

9.  Suppression of the humoral antibody response in natural retrovirus infections.

Authors:  Z Trainin; D Wernicke; H Ungar-Waron; M Essex
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

10.  Suppression of human lymphocyte mitogen response by disrupted primate retroviruses of type C (baboon endogenous virus) and type D (PMFV).

Authors:  J Denner; V Wunderlich; D Bierwolf
Journal:  Acta Biol Med Ger       Date:  1980
View more
  20 in total

1.  Biological activities of a synthetic peptide composed of two unlinked domains from a retroviral transmembrane protein sequence.

Authors:  D E Wegemer; K G Kabat; W S Kloetzer
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

Review 2.  Retrovirus and filovirus "immunosuppressive motif" and the evolution of virus pathogenicity in HIV-1, HIV-2, and Ebola viruses.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

3.  Inhibition of lymphoproliferation and protein kinase C by synthetic peptides with sequence identity to the transmembrane and Q proteins of visna virus.

Authors:  C L Ruegg; J E Clements; M Strand
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

4.  Identification, using synthetic peptides, of the minimum amino acid sequence from the retroviral transmembrane protein p15E required for inhibition of lymphoproliferation and its similarity to gp21 of human T-lymphotropic virus types I and II.

Authors:  C L Ruegg; C R Monell; M Strand
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

5.  Recombinant hydrophilic region of murine retroviral protein p15E inhibits stimulated T-lymphocyte proliferation.

Authors:  D M Schmidt; N K Sidhu; G J Cianciolo; R Snyderman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

6.  Synthetic peptide homologous to the envelope proteins of retroviruses shares a cross-reacting epitope with the CD4 receptor.

Authors:  J Rothmann; N F Hassan; D E Campbell; N Kamani; S D Douglas
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

7.  Induction of intracellular cAMP by a synthetic retroviral envelope peptide: a possible mechanism of immunopathogenesis in retroviral infections.

Authors:  S Haraguchi; R A Good; M James-Yarish; G J Cianciolo; N K Day
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

8.  In vivo effects of thymostimulin treatment on monocyte polarization, dendritic cell clustering and serum p15E-like trans-membrane factors in operable head and neck squamous cell carcinoma patients.

Authors:  J D Kerrebijn; P J Simons; M Tas; A J Balm; H A Drexhage
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

9.  Comparison of retroviral p15E-related factors and interferon alpha in head and neck cancer.

Authors:  P J Simons; R A Oostendorp; M P Tas; H A Drexhage
Journal:  Cancer Immunol Immunother       Date:  1994-03       Impact factor: 6.968

10.  Sensitivity and specificity of a recombinant transmembrane glycoprotein (rgp21)-spiked western immunoblot for serological confirmation of human T-cell lymphotropic virus type I and type II infections.

Authors:  R B Lal; S Brodine; J Kazura; E Mbidde-Katonga; R Yanagihara; C Roberts
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.